Top member reports
Consensus community valuation
$0.540
Average Intrinsic Value
1592.7%
Undervalued by
Active Member Straws
#Bull Case
Added 3 months ago

And in case you missed it from a few weeks ago

Imugene will trial PD1-Vaxx in patients with non-small cell lung cancer

Will 2020 be the start of immunotherapy dishing out a fatal blow to many forms of cancer? I hope so!

Read More
#Bull Case
Last edited 3 months ago

Imugene has checkvacc preclinical data published in the journal of american college of surgeons

Positive results for pancreatic cancer but pushing ahead with testing in patients with Triple-Negative Breast Cancer (TNBC) which had equally positive pre-clinical data.

Read More